Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule

Abstract This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5) administered on an alternative schedule (initiated at 2–5 weeks of age) with those of RV5 administered on the recommended standard schedule. Our findings support the future conduct of larger clinical tr...

Ausführliche Beschreibung